Enhanced Photocatalytic and Photokilling Activities of Cu-Doped TiO2 Nanoparticles

The Catalytic Role of Superparamagnetic Iron Oxide Nanoparticles as a Support Material for TiO2 and ZnO on Chlorpyrifos Photodegradation in an Aqueous Solution

Chlorpyrifos (CP) is a globally used pesticide with acute toxicity. This work studied the photocatalytic degradation of CP using TiO2, ZnO nanoparticles, and nanocomposites of TiO2 and ZnO supported on SPIONs (SPION@SiO2@TiO2 and SPION@SiO2@ZnO). The nanocomposites were synthesized by multi-step incipient wetness impregnation. The effects of the initial pH, catalyst type, and dose were evaluated. The nanocomposites of SPION@SiO2@TiO2 and SPION@SiO2@ZnO showed higher CP photodegradation levels than free nanoparticles, reaching 95.6% and 82.3%, respectively, at pH 7. The findings indicate that iron oxide, as a support material for TiO2 and ZnO, extended absorption edges and delayed the electron-hole recombination of the nanocomposites, improving their photocatalytic efficiency. At the same time, these nanocomposites, especially SPION@SiO2@TiO2, showed efficient degradation of 3,5,6-trichloropyridinol (TCP), one of the final metabolites of CP. The stability and reuse of this nanocomposite were also evaluated, with 74.6% efficiency found after six cycles. Therefore, this nanomaterial represents an eco-friendly, reusable, and effective alternative for the degradation of chlorpyrifos in wastewater treatment.

Synthesis, Characterization and Performance of Materials for a Sustainable Future

Today, sustainability represents the key factor for economic progress in compliance with social advancement and environmental protection, driving innovation in materials, processes and technologies [...].

Low-Temperature Synthesis of Cu-Doped Anatase TiO2 Nanostructures via Liquid Phase Deposition Method for Enhanced Photocatalysis

Titanium dioxide (TiO₂) photocatalysis can harness the energy from sunlight, providing a solution to many green- and energy-related problems. In this study, we aimed to produce Cu doped TiO₂ (Cu-TiO₂) structures at a low temperature (~70 °C) under atmospheric pressure based on liquid phase deposition. The products prepared with Cu nitrate exhibited anatase-phase TiO₂ with the presence of Cu, and the particles showed a waxberry-like structure. Changing the Cu nitrate concentration allowed control of the atomic concentration; we confirmed ~1.3 atm.% of Cu ions in the product when we applied 10 mM in the precursor solution. By doping Cu, the light absorption edge shifted to 440 nm (~2.9 eV), and we proved the photocatalytic reaction through action spectral measurement. We observed the decomposition of acetaldehyde into CO₂ on Cu-TiO₂ photocatalysts, which produced optimized improvements in photocatalytic activity at Cu dopant levels between 0.2 and 0.4 atm.%. This study demonstrates that the liquid phase deposition technique can be used for doping metallic ions into TiO₂, which shows promise for preparing novel and unique nanomaterials as visible light photocatalysts.

CuO-TiO2-Chitosan-Berbamine Nanocomposites Induce Apoptosis through the Mitochondrial Pathway with the Expression of P53, BAX, and BCL-2 in the Human K562 Cancer Cell Line

In this study, cells from human Chronic Myelogenous Leukemia (K562) were cultivated with CuO-TiO2-Chitosan-Berbamine nanocomposites. We examined nanocomposites using XRD, DLS, FESEM, TEM, PL, EDAX, and FTIR spectroscopy, as well as MTT for cytotoxicity, and AO/EtBr for apoptotic morphology assessment. The rate of apoptosis and cell cycle arrests was determined using flow cytometry. Flow cytometry was also employed to identify pro- and antiapoptotic proteins such as Bcl2, Bad, Bax, P53, and Cyt C. The FTIR spectrum revealed that the CuO-TiO2-Chitosan-Berbamine nanocomposites were electrostatically interlocked. The nanocomposites' XRD signals revealed a hexagonal shape. In the DLS spectrum, nanocomposites were found to have a hydrodynamic diameter. As a result of their cytotoxic action, nanocomposites displayed concentration-dependent cytotoxicity. The nanocomposites, like Doxorubicin, caused cell cycle phase arrest in K562 cells. After treatment with IC50 concentrations of CuO-TiO2-Chitosan-Berbamine nanocomposites and Doxorubicin, a substantial percentage of cells were in G2/M stage arrest. Caspase-3, -7, -8, -9, Bax, Bad, Cyt C, and P53 expression were considerably enhanced in K562 cells, whereas Bcl2 expression was decreased, indicating that these cells may have therapeutic potential against human blood cancer/leukemia-derived disorders. As a result, the nanocomposites demonstrated outstanding anticancer potential against leukemic cells. CuO-TiO2-Chitosan-Berbamine, according to our findings.